Entering text into the input field will update the search result below

Amgen deal for Horizon likely to go through despite FTC objection: Guggenheim

May 17, 2023 11:33 AM ETAmgen Inc. (AMGN) Stock, HZNP StockBy: Jonathan Block, SA News Editor5 Comments
Amgen sign at its headquarters in Thousand Oaks, California, USA.

JHVEPhoto

The Federal Trade Commission's lawsuit seeking to block Amgen's (NASDAQ:AMGN) acquisition of Horizon Therapeutics (NASDAQ:HZNP) will be unsuccessful given the high bar the agency is up against, according to Guggenheim.

Analyst Michael Schmidt said that while the FTC's action provides

Recommended For You

Related Stocks

SymbolLast Price% Chg
AMGN
--
HZNP
--